Prostate Cancer Essay

History In 2013 there were 238,500 new cases of Prostate Cancer diagnosed in the United Sates, and about 29,700 of the cases will die from it according to WebMD.com. Prostate Cancer is the most non-skin related cancer in the United States. Prostate cancer is the formation of cancerous cells in the prostate of the male’s reproductive organ. Prostate cancer is a slow progressing disease, and most men only die once they have reached old age. Because the prostate is in close proximity to other organs, it also

Sicsic Fall 2014 Carcinoma of the prostate, commonly known as prostate cancer, is a diagnosis of a "malignant tumor (adenocarcinoma) of the prostate gland" (Chabner). The prostate is a significant muscular organ that belongs to the male reproductive system. Approximately the size of a walnut, the prostate is "located at the base of the bladder and in front of the rectum" (Prostate Gland). In conjunction to the seminal vesicles and the Cowper 's glands, the prostate secretes fluids that contain "sperm

Introduction Prostate Cancer (PCa) is the most common cancer affecting men and the second leading cause of cancer death among American men (Qaseem, Denberg, Owens, & Shekelle, 2013). Medical professionals have been using prostate specific antigen (PSA) screenings along with digital rectal exam (DRE) for many years to screen for prostate cancer. PSA was first identified in 1966 in semen, followed by the identification of PSA in blood in 1979. The PSA test has been approved for use since 1994 to detect

Introduction According to Anderson and Marshall-Lucette (2016), prostate cancer is the second leading cause of deaths in developed countires with the highest incidence in diagnoses for males worldwide. (p1046) “African American men have the highest incidence of prostate cancer, with a 1 in 5 probability of getting prostate cancer with the lowest rate of participation in prostate cancer screening. (Sandiford & D’Errico, 2015, p.86) The Health Belief Model was constructed to help understand behavior

Prostate cancer is the most prevalent nonskin cancer among men in the United States and is the second leading cause of cancer death in men. While prostate cancer is most regularly diagnosed in men at the age of 65 years and older, the occurrence can begin at 50. One in 6 men will be diagnosed with prostate cancer during their lifetime. As researchers explore this form of cancer; men also need to know it’s essential to understand early prostate cancer is treatable. By these patients exploring these

Prostate cancer is a cancer relating to the prostate, a gland located in front of the rectum and below the urinary bladder (ACS 2015). Prostate cancer only affects the male population because the prostate gland is only found in the male reproductive system (FIS 2015). Among the males in the world, certain males are at higher risk than others due to certain risk factors. One of the biggest risk factors is age (PCF 2015). Only 1 in 10000 men under the age of 40 will be diagnosed with prostate cancer

According to the Prostate Cancer Foundation, African American men are a staggering 1.6 times more likely to develop prostate cancer than Caucasian men and and overwhelming 2.4 times more likely to die from prostate cancer compared to caucasian men. As odd as it might sound, African American men living in the United States have the highest risk factor in the world for prostate cancer. African American men living in the United States are a whopping 60 times more likely to develop prostate cancer than men living

glucose and prostate cancer death, but no associations were observed for triglycerides and total cholesterol. Similar positive associations were seen for glucose and triglycerides with overall, CVD or other deaths. Hypercholesterolemia was positively associated with CVD death. Glucose Consistent with other studies we found positive associations between glucose and prostate cancer death (10,29). Other studies yielded non-significant associations between diabetes and prostate cancer death, but the

NON-TECHNICAL SUMMARY Prostate cancer (PCa) is the most common solid malignancy and the second leading cause of cancer death in men, however, a large number of newly diagnosed PCa are indolent. Patients with indolent PCa have to undergo similar treatment as aggressive PCa and suffer from cost and side effect of treatment, compromising the quality of life and potential morbidity without any benefit. FDA has approved Prostate Specific Antigen (PSA) assessment for screening for PCa. However, ubiquitous

Introduction: Prostate cancer is the most common cancer in New Zealand and third most common cause of cancer death in the male population. Serum prostate-specific antigen (PSA) level is generally used as a screening test for asymptomatic patients. Patients with elevated serum PSA level and/or abnormal digital rectal examination undergo Transrectal ultrasound (TRUS) guided biopsy to detect early prostatic carcinoma. The histological grade of the cancer usually assessed using the Gleason grading